100 related articles for article (PubMed ID: 15812242)
1. DNA shuffling and screening strategies for improving vaccine efficacy.
Locher CP; Paidhungat M; Whalen RG; Punnonen J
DNA Cell Biol; 2005 Apr; 24(4):256-63. PubMed ID: 15812242
[TBL] [Abstract][Full Text] [Related]
2. Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine.
Dupuy LC; Locher CP; Paidhungat M; Richards MJ; Lind CM; Bakken R; Parker MD; Whalen RG; Schmaljohn CS
Vaccine; 2009 Jun; 27(31):4152-60. PubMed ID: 19406186
[TBL] [Abstract][Full Text] [Related]
3. Overcoming antigenic diversity and improving vaccines using DNA shuffling and screening technologies.
Locher CP; Heinrichs V; Apt D; Whalen RG
Expert Opin Biol Ther; 2004 Apr; 4(4):589-97. PubMed ID: 15102607
[TBL] [Abstract][Full Text] [Related]
4. Development of novel vaccines using DNA shuffling and screening strategies.
Locher CP; Soong NW; Whalen RG; Punnonen J
Curr Opin Mol Ther; 2004 Feb; 6(1):34-9. PubMed ID: 15011779
[TBL] [Abstract][Full Text] [Related]
5. Vaccine Advances against Venezuelan, Eastern, and Western Equine Encephalitis Viruses.
Stromberg ZR; Fischer W; Bradfute SB; Kubicek-Sutherland JZ; Hraber P
Vaccines (Basel); 2020 Jun; 8(2):. PubMed ID: 32503232
[TBL] [Abstract][Full Text] [Related]
6. Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen.
Apt D; Raviprakash K; Brinkman A; Semyonov A; Yang S; Skinner C; Diehl L; Lyons R; Porter K; Punnonen J
Vaccine; 2006 Jan; 24(3):335-44. PubMed ID: 16125280
[TBL] [Abstract][Full Text] [Related]
7. A chimeric tetravalent dengue DNA vaccine elicits neutralizing antibody to all four virus serotypes in rhesus macaques.
Raviprakash K; Apt D; Brinkman A; Skinner C; Yang S; Dawes G; Ewing D; Wu SJ; Bass S; Punnonen J; Porter K
Virology; 2006 Sep; 353(1):166-73. PubMed ID: 16814355
[TBL] [Abstract][Full Text] [Related]
8. In vitro rapid evolution of fungal immunomodulatory proteins by DNA family shuffling.
Wang XF; Li QZ; Bao TW; Cong WR; Song WX; Zhou XW
Appl Microbiol Biotechnol; 2013 Mar; 97(6):2455-65. PubMed ID: 22615051
[TBL] [Abstract][Full Text] [Related]
9. DNA vaccines expressing antigens with a stress protein-capturing domain display enhanced immunogenicity.
Reimann J; Schirmbeck R
Immunol Rev; 2004 Jun; 199():54-67. PubMed ID: 15233726
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
Zhou C; Peng G; Jin X; Tang J; Chen Z
Clin Immunol; 2010 Nov; 137(2):190-8. PubMed ID: 20692873
[TBL] [Abstract][Full Text] [Related]
11. DNA vaccination: antigen presentation and the induction of immunity.
Shedlock DJ; Weiner DB
J Leukoc Biol; 2000 Dec; 68(6):793-806. PubMed ID: 11129646
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma.
Timmerman JM; Singh G; Hermanson G; Hobart P; Czerwinski DK; Taidi B; Rajapaksa R; Caspar CB; Van Beckhoven A; Levy R
Cancer Res; 2002 Oct; 62(20):5845-52. PubMed ID: 12384547
[TBL] [Abstract][Full Text] [Related]
14. Molecular breeding of allergy vaccines and antiallergic cytokines.
Punnonen J
Int Arch Allergy Immunol; 2000 Mar; 121(3):173-82. PubMed ID: 10729775
[TBL] [Abstract][Full Text] [Related]
15. CpG/Poly (I:C) mixed adjuvant priming enhances the immunogenicity of a DNA vaccine against eastern equine encephalitis virus in mice.
Ma J; Wang H; Zheng X; Xue X; Wang B; Wu H; Zhang K; Fan S; Wang T; Li N; Zhao Y; Gao Y; Yang S; Xia X
Int Immunopharmacol; 2014 Mar; 19(1):74-80. PubMed ID: 24440303
[TBL] [Abstract][Full Text] [Related]
16. Combined immunotherapy of breast cancer with EGF and VEGF vaccines from DNA shuffling in a mouse model.
Jin D; Yu X; Chen B; Li Z; Ding J; Zhao X; Qi G
Immunotherapy; 2017 Jun; 9(7):537-553. PubMed ID: 28509606
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic T-lymphocyte-, and helper T-lymphocyte-oriented DNA vaccination.
Nagata T; Aoshi T; Uchijima M; Suzuki M; Koide Y
DNA Cell Biol; 2004 Feb; 23(2):93-106. PubMed ID: 15000749
[TBL] [Abstract][Full Text] [Related]
18. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
19. Noncarrier naked antigen-specific DNA vaccine generates potent antigen-specific immunologic responses and antitumor effects.
Chen CA; Chang MC; Sun WZ; Chen YL; Chiang YC; Hsieh CY; Chen SM; Hsiao PN; Cheng WF
Gene Ther; 2009 Jun; 16(6):776-87. PubMed ID: 19357714
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of a new HIV-1 DNA construct in a BALB/c mouse model.
Mahdavi M; Ebtekar M; Mahboudi F; Khorram Khorshid H; Rahbarizadeh F; Azadmanesh K; Darabi H; Pourasgari F; Hassan ZM
Iran J Immunol; 2009 Dec; 6(4):163-73. PubMed ID: 20054104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
